Basal Ganglia Dopamine Availability and Immune Activation Interact and Relate to Anhedonia Severity among Youth with Depression

Read full text
Authors: Iris Ka-Yi Chat, James W. Murrough, Scott J. Russo, Finnegan Calabro, Beatriz Luna, Kalyan Tripathy, Tina Gupta, Zachary Brodnick, Megan M. Julien, Neil Jones, Neal Ryan, Helmet Talib Karim
+3 more Rebecca B. Price, Jihui Diaz, Erika E. Forbes
Cited by: 1

Abstract

Abstract Anhedonia emerges in adolescence, has putative substrates in neural reward and dopamine systems, and is a hallmark of poor course in depression. Psychoneuroimmunology models suggest altered immune and reward systems may jointly underlie its development. When dopamine availability (rather than function) is considered, immune activation may be understood as a moderator amplifying how lower dopamine levels translate into motivational deficits. This cross-sectional study analyzed data from 55 youth with current depression (Mage=21.4 years; Female=75%). Plasma was assayed for relative quantification of 92 immune proteins, followed by dimensionality reduction via principal component (PC) analysis, forming five PC scores. Dopamine availability was indexed by basal ganglia tissue iron, quantified by MRI R2’, a measure detectable in youth. Anhedonia was assessed using the Snaith–Hamilton Pleasure Scale (SHAPS), thought to capture overall anhedonia, and Positive Valence Systems Scale (PVSS), which provides overall, anticipatory, and consummatory anhedonia scores. PC1 scores—whose loadings indicated broadly distributed immune protein elevations consistent with general immune activation—moderated the relationship between basal ganglia dopamine availability and anhedonia: At higher PC1 levels, lower dopamine availability was linked to greater overall anhedonia (as measured by SHAPS) and anticipatory anhedonia, but not to consummatory anhedonia. Lower PC2 scores were associated with greater PVSS overall and consummatory anhedonia. Analyses examining individual basal ganglia regions suggest potential differences in dopaminergic-immune interactions across these regions, with effects most consistently observed in the putamen. Findings highlight nuanced neuroimmune pathways underlying anhedonia components in youth and support inflammation-based models of depression emphasizing dopaminergic-immune interplay.

Fields of Study & Subjects

Tryptophan and brain disorders Mental Health Research Topics Anxiety Depression Psychometrics Treatment Cognitive Processes

Publication details

Journal / source
Research Square
Publisher
Springer Science and Business Media LLC
Publication date
12 February 2026
Language
EN
Document type
Preprint